News | April 07, 2025
Sumitomo Chemical establishes a CRO for Oligonucleotide CDMO business in US
Sumitomo Chemical began its nucleic acid drug substance contract manufacturing business in 2013
Sumitomo Chemical began its nucleic acid drug substance contract manufacturing business in 2013
This collaboration positions WACKER and RNAV8 as premium mRNA service providers
Being a premium partner for pharmaceutical companies by contributing to safety and productivity of pharmaceutical manufacture
Nadda noted that TB treatment coverage in India has increased from 59% to 85%
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
Company expects to begin building four more domestic manufacturing sites this year and add 13,000 high-wage manufacturing and construction jobs in America
Among those identified, 2.4 lakh patients have been notified from public health institutions, while 1.1 lakh were identified through private healthcare facilities
Pascal Villemagne has announced his intent to step down at the end of March 2025, to take on a new challenge in his professional career.
SynerK owns intellectual property rights of SNK-2726, which is currently in the IND filing preparation stage
Divestment is part of BASF’s strategic portfolio optimization
Subscribe To Our Newsletter & Stay Updated
